Company intelligence
PepGen
Better Technology. Better Delivery. Developing a new generation of disease-modifying therapies.
Biotechnology Research
Boston, US
65 employees
Founded 2018
2 public signals
About PepGen
Driven by our proprietary Enhanced Delivery Oligonucleotide (EDO) platform, we are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic neuromuscular and neurological disorders.
Verified activity
Signals from PepGen
2 published signals
Presence & Recognition
PepGen is attending the 27th Annual Neuromuscular Study Group Scientific Meeting in San Antonio, Texas from September 25–27 and the 31st Annual Congress of the World Muscle Society in Hiroshima, Japan from September 29–October 3.
Reported by PepGen
Presence & Recognition
PepGen participated in the Wellness Bingo Challenge during National Wellness Month, encouraging employees to complete wellness-focused activities.
Reported by PepGen